UC Berkeley loses CRISPR patent case, invalidating licenses it granted gene-editing companies Ending a years-long legal battle over who invented CRISPR, the U.S. Patent and Trademark Office ruled on Monday that the revolutionary genome editing technology belongs to the Broad Institute of Harvard and MIT. The decision is a huge blow to the University of California and biotech companies that had licensed the technology from the university for use in developing treatments. Read more If you’d like to stop receiving these alerts, click on the "update email preferences" link below. | 
No comments